| (CHF) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -12.65M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MOLN.SW returned +18.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +4.3% |
| 1 year | +18.5% |
| 5 years | -81.7% |
| 10 years | -84.8% |
| All-time high | CHF 35.95 (Oct 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what CHF1,000 in MOLN.SW would be worth today ›No. Molecular Partners AG has not paid a dividend in the past 12 months.
Molecular Partners AG is part of the Healthcare sector.
Molecular Partners AG has a market cap of 132.41M CHF, based on the latest quote.